FrancophonIA/ELRC3.0 huggingface dataset:
English: Precipitation of opioid withdrawal syndrome
Maltese: Epatite akuta Suffejra Sindrome
English: 6.1 List of excipients
Maltese: FARMAĊEWTIKU 6.1 Lista ta' eċċipjenti Lactose monohydrate
English: Read all of this leaflet carefully before you start taking this because it contains important information for you.
Maltese: Id-data ta' skadenza tirreferi għall aħħar ġurnata ta' dak ix-xahar.
English: Swollen glands (lymph nodes), agitation, tremor, abnormal dream, excessive muscle activity, depersonalisation (not feeling like yourself), medicine dependence, amnesia (memory disturbance), loss of interest, exaggerated feeling of well being, convulsion (fits), speech disorder, small pupil size, difficulty urinating, eye inflammation or infection, rapid or slow heart beat, low blood pressure, palpitations, myocardial infarction (heart attack), chest tightness, shortness of breath, asthma, yawning, pain and sores in mouth, tongue discolouration, acne, skin nodule, hair loss, dry or scaling skin, inflammation of joints, urinary tract infection, abnormal blood tests, blood in urine, abnormal ejaculation, menstrual or vaginal problems, kidney stone, protein in your urine, painful or difficult urination, sensitivity to heat or cold, heat stroke, loss of appetite, feelings of hostility.
Maltese: Effetti sekondarji mhux komuni (jistgħu jaffettwaw sa persuna 1minn kull 100): Glandoli minfuħin (glandoli limfatiċi), aġitazzjoni, rogħda, ħolm anormali, attività eċċessiva tal-muskoli, dipersonalizzazzjoni (ma tħossokx li int fiha), dipendenza fuq il-mediċina, amnesija (disturbi tal-memorja), telf ta' interess, sensazzjoni esaġerata ta' benesseri, konvulżjoni (aċċessjonijiet), disturb fid-diskors, daqs żgħir tal-pupilla, diffikultà biex tgħaddi lawrina, infjammazzjoni jew infezzjoni fl-għajnejn, taħbit tal-qalb mgħaġġel jew bil-mod, pressjoni baxxa tad-demm, palpitazzjonijiet, infart mijokardijaku (attakk tal-qalb), tagħfis fissider, qtugħ ta' nifs, ażma, titwib, uġigħ u feriti fil-ħalq, telf ta' kulur fl-ilsien, akne, għoqod filġilda, jaqa' x-xagħar, ġilda xotta jew qxur tal-ġilda, infjammazzjoni tal-ġogi, infezzjoni flapparat urinarju, testijiet tad-demm b'riżultat mhux normali, demm fl-awrina, ejakulazzjoni mhux normali, problemi mestrwali jew tal-vaġina, ġebel fil-kliewi, proteina fl-awrina tiegħek , awrina bl-uġigħ jew diffiċli, sensittività għas-sħana jew għall-ksieħ, puplesija kkawżata missħana, telf ta' aptit, sensazzjonijiet ta' ostilità.
English: Sublingual tablet White round biconvex tablets of 10.5 mm with “N16” debossed on one side.
Maltese: Abjad pilloli bikonvessi round ta ' 10.5
English: Hyperhidrosis Pruritus Rash
Maltese: FULJETT TA' TAGĦRIF
English: Swollen glands (lymph nodes), agitation, tremor, abnormal dream, excessive muscle activity, depersonalisation (not feeling like yourself), medicine dependence, amnesia (memory disturbance), loss of interest, exaggerated feeling of well being, convulsion (fits), speech disorder, small pupil size, difficulty urinating, eye inflammation or infection, rapid or slow heart beat, low blood pressure, palpitations, myocardial infarction (heart attack), chest tightness, shortness of breath, asthma, yawning, pain and sores in mouth, tongue discolouration, acne, skin nodule, hair loss, dry or scaling skin, inflammation of joints, urinary tract infection, abnormal blood tests, blood in urine, abnormal ejaculation, menstrual or vaginal problems, kidney stone, protein in your urine, painful or difficult urination, sensitivity to heat or cold, heat stroke, loss of appetite feelings of hostility.
Maltese: Effetti sekondarji mhux komuni (jistgħu jaffettwaw sa persuna 1minn kull 100): Glandoli minfuħin (glandoli limfatiċi), aġitazzjoni, rogħda, ħolm anormali, attività eċċessiva tal-muskoli, dipersonalizzazzjoni (ma tħossokx li int fiha), dipendenza fuq il-mediċina, amnesija (disturbi tal-memorja), telf ta' interess, sensazzjoni esaġerata ta' benesseri, konvulżjoni (aċċessjonijiet), disturb fid-diskors, daqs żgħir tal-pupilla, diffikultà biex tgħaddi lawrina, infjammazzjoni jew infezzjoni fl-għajnejn, taħbit tal-qalb mgħaġġel jew bil-mod, pressjoni baxxa tad-demm, palpitazzjonijiet, infart mijokardijaku (attakk tal-qalb), tagħfis fissider, qtugħ ta' nifs, ażma, titwib, uġigħ u feriti fil-ħalq, telf ta' kulur fl-ilsien, akne, għoqod filġilda, jaqa' x-xagħar, ġilda xotta jew qxur tal-ġilda, infjammazzjoni tal-ġogi, infezzjoni flapparat urinarju, testijiet tad-demm b'riżultat mhux normali, demm fl-awrina, ejakulazzjoni mhux normali, problemi mestrwali jew tal-vaġina, ġebel fil-kliewi proteina fl-awrina tiegħek , awrina bl-uġigħ jew diffiċli,, sensittività għas-sħana jew għall-ksieħ, puplesija kkawżata missħana, sensazzjonijiet ta' ostilità.
English: Weight loss, swelling (hands and feet), drowsiness, anxiety, nervousness, tingling, depression, decreased sexual drive, increase in muscle tension, abnormal thinking, increased tearing (watering eyes) or other tearing disorder, blurred vision, flushing, increased blood pressure, migraines, runny nose, sore throat and painful swallowing, increased cough, upset stomach or other stomach discomfort, diarrhoea, abnormal liver function, flatulence, vomiting, rash, itching, hives, pain, joint pain, muscle pain, leg cramps (muscle spasm), difficulty in getting or keeping an erection, urine abnormality, abdominal pain, back pain, weakness, infection, chills, chest pain, fever, flu-like symptoms, feeling of general discomfort, accidental injury caused by loss of alertness or co-ordination, faintness and dizziness.
Maltese: Telf ta' piż, nefħa (fl-idejn u fis-saqajn), , ngħas, ansjetà, nervożità, tnemnim, depressjoni, tnaqqis fil-ħajra sesswali, żieda fit-tensjoni tal-muskoli, ħsibijiet mhux normali, ħruġ ta' dmugħ aktar mis-soltu (għajnejn bid-dmugħ) jew disturbi oħrajn fil-produzzjoni tad-dmugħ, vista mċajpra, fwawar, żieda fil-pressjoni tad-demm, emigranji, imnieħer inixxi, uġigħ fil-griżmejn u wġigħ biex tibla', żieda fis-sogħla, stonku mqalleb jew skumdità oħra fl-istonku, dijarea, funzjoni mhux normali tal-fwied, gass, rimettar, raxx, ħakk, ħorriqija, uġigħ, uġigħ fil-ġogi, uġigħ fil-muskoli, bugħawwieġ fir-riġlejn (spażmu fil-muskoli), diffikultà biex tikseb jew biex iżżomm erezzjoni, awrina mhux normali, uġigħ addominali, uġigħ fid-dahar, dgħufija, infezzjoni, tkexkix ta' bard, uġigħ fis-sider, deni, sintomi li jixbhu l-influwenza, sensazzjoni ta' skonfort ġenerali, korriment aċċidentali kkawżat minn telf ta' prontezza jew koordinazzjoni, ħass ħażin u sturdament,.
English: Overall, buprenorphine plasma exposure increased approximately 3-fold in patients with severely impaired hepatic function, while naloxone plasma exposure increased 14-fold with severely impaired hepatic function.
Maltese: Kollox ma 'kollox, l-espożizzjoni ta' buprenorphine fil-plażma żdiedet b'madwar 3 darbiet f'pazjenti b'funzjoni epatika indebolita severament, filwaqt li l- espożizzjoni ta' naloxone fil-plażma żdiedet b'14 -il darba b'funzjoni epatika indebolita severament.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS PACK OF 7 and 28 TABLETS 8 mg STRENGTH
Maltese: TAGĦRIF LI GĦANDU JIDHER FUQ IL-PAKKETT TA' BARRA PAKKETT TA' 7 u 28 PILLOLA B'QAWWA TA' 8 mg
English: MARKETING AUTHORISATION NUMBER(S) EU/1/06/359/003 8 mg sublingual tablets 7
Maltese: FIS-SUQ EU/1/06/359/003 8 mg pilloli għal taħt l-ilsien 7
English: Cough
Maltese: mard
English: For subjects randomized to either active treatment, dosing began with 8 mg of buprenorphine on Day 1, followed by 16 mg (two 8 mg) of buprenorphine on Day 2.
Maltese: Għal persuni li ġew assenjati b'mod każwali għal xi waħda minn dawn il-kuri attivi, l-għoti tad-dożi beda bi 8 mg ta' buprenorphine f'Jum 1, segwit minn 16-il mg (żewġ dożi ta' 8 mg) ta' buprenorphine f'Jum 2.
English: barbiturates (used to cause sleep or sedation) such as Phenobarbital, secobarbital tranquilisers (used to cause sleep or sedation) such as chloral hydrate.
Maltese: - barbiturati (użati biex jikkaġunaw l-irqad jew is-sedazzjoni) bħal Phenobarbital, secobarbital.
English: INFORMATION IN BRAILLE Suboxone 2 mg/0.5 mg sublingual tablets
Maltese: Suboxone 2 mg/0.5 mg pilloli għal taħt l-ilsien
English: Some reports of seizure, vomiting, diarrhoea, and elevated liver function tests were considered serious.
Maltese: Xi rapporti ta' aċċessjoni, rimettar, dijarea, u testijiet tal-funzjoni tal-fwied b'riżultat għoli kienu meqjusa bħala serji.
English: Medicines that inhibit the enzyme CYP3A4 may give rise to increased concentrations of buprenorphine.
Maltese: Mediċini li jinibixxu l-enzima CYP3A4 jistgħu jirriżultaw f'żieda fil-konċentrazzjonijiet ta' buprenorphine.
English: Buprenorphine, when taken orally, undergoes first-pass metabolism with N-dealkylation and glucuroconjugation in the small intestine and the liver.
Maltese: Meta jittieħed b'mod orali, buprenorphine jgħaddi minn metaboliżmu first-pass b'N dealkylation u glukurokonjugazzjoni fil-musrana ż-żgħira u l-fwied.
English: Caution is recommended when dosing patients with severe renal impairment (creatinine clearance <30 ml/min) (see sections 4.2 and 5.2).
Maltese: <30 ml/min) (ara sezzjonijiet 4.2 u 5.2).
English: INFORMATION IN BRAILLE Suboxone 16 mg/4 mg sublingual tablets
Maltese: Suboxone 16 mg/4 mg pilloli għal taħt l-ilsien
English: The long half life of methadone should be considered when starting buprenorphine/naloxone.
Maltese: Il-half-life twila ta' methadone għandha tiġi kkunsidrata meta tibda l-kura bi buprenorphine/naloxone.
English: The lowest dose studied represented exposure multiples of 1x for buprenorphine and 5x for naloxone at the maximum human therapeutic dose calculated on a mg/m² basis.
Maltese: Dawn it-tipi ta' mediċini sejrin inaqqsu l-livelli ta' prontezza tiegħek u jagħmluhielek diffiċli biex issuq u tuża makkinarji.
English: Lactose monohydrate Mannitol
Maltese: 64 mg ta' lactose (kif monohydrate)
English: 78 mg/g Gel
Maltese: 78 mg/g Ġel
English: Cutaneous use tube (alu) 2 g
Maltese: Użu taħt il-ġilda tubu (alu) 2 g tubu 1
English: 1 tube
Maltese: Daqs talpakkett
English: 5 April 2016 EMA/147173/2016
Maltese: EMA/147173/2016
English: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom production of urine in order to achieve flushing of the urinary tract.
Maltese: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom
English: For dry extracts the solvent is then evaporated.
Maltese: Għal estratti niexfa is-solvent imbagħad jiġi evaporat.
English: Horsetail herb is the common name for the aerial parts of the plant Equisetum arvense L.
Maltese: Denb iż-żiemel huwa l-isem komuni għall-partijiet ta' fuq tal-pjanta Equisetum arvense L.
English: The HMPC conclusions on the use of horsetail herb medicines for minor urinary complaints and for superficial wounds are based on their ‘traditional use'.
Maltese: Il-konklużjonijiet tal-HMPC dwar l-użu tal-mediċini li fihom denb iż-żiemel għal ilmenti minuri urinarji u għal ġrieħi superfiċjali huma bbażati fuq l-"użu tradizzjonali" tagħhom.
English: Horsetail herb medicines should be used only in adults and adolescents over the age of 12 years.
Maltese: Il-mediċini li fihom denb iż-żiemel għandhom jintużaw biss f'adulti u adoloxxenti li għandhom 'il fuq minn 12-il sena.
English: In its assessment, the HMPC considered a clinical study in healthy male volunteers comparing a horsetail herb preparation with a dummy treatment and a medicine that increases the volume of urine produced (a diuretic).
Maltese: Fil-valutazzjoni tiegħu, l-HMPC ikkunsidra studju kliniku f'voluntiera rġiel f'saħħithom li jqabbel ilpreparazzjoni ta' denb iż-żiemel ma' kura finta u mediċina li żżid il-volum tal-awrina prodotta (dijuretika).
English: What are the risks associated with horsetail herb medicines?
Maltese: X'inhuma r-riskji assoċjati mal-mediċini li fihom denb iż-żiemel?
English: Side effects have been reported with horsetail herb medicines.
Maltese: Ġew irrapportati effetti sekondarji bil-mediċini li fihom denb iż-żiemel.
English: Further information on the HMPC assessment of horsetail herb medicines, including details of the Committee's conclusions, can be found under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Maltese: Aktar informazzjoni dwar il-valutazzjoni tal-HMPC tal-mediċini li fihom denb iż-żiemel, inklużi d-dettalji tal-konklużjonijiet tal-Kumitat, tinsab taħt it-tab ‘Id-dokumenti kollha' (All Documents') fil-websajt talAġenzija:
English: Although the results from this study indicated that the horsetail herb preparation did have a mild diuretic effect, only a few individuals were included in the study and the information on the preparation used was limited.
Maltese: Għalkemm ir-riżultati minn dan l-istudju jindikaw li l-preparazzjoni ta' denb iż-żiemel kellha effett dijuretiku ħafif, ftit individwi biss kienu inklużi fl-istudju u l-informazzjoni dwar ilpreparazzjoni użata kienet limitata.
English: Other information about horsetail herb medicines
Maltese: Aktar informazzjoni dwar il-mediċini li fihom denb iż-żiemel
English: Further information on the risks associated with horsetail herb medicines, including the appropriate precautions for their safe use, can be found in the monograph under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Maltese: Aktar informazzjoni dwar ir-riskji assoċjati ma' dawn il-mediċini li fihom denb iż-żiemel, inklużi lprekawzjonijiet xierqa għall-użu sigur tagħhom, tinsab fil-monografija taħt it-tab ‘Id-dokumenti kollha' (All Documents') fil-websajt tal-Aġenzija:
English: Extracts are prepared using a technique to extract compounds from plant material by putting the plant material in a solvent (such as ethanol or water) to dissolve compounds and form a liquid extract.
Maltese: L-estratti huma mħejjija bl-użu ta' teknika għall-estrazzjoni ta' komponenti mill-materjal tal-pjanta billi tpoġġi il-materjali tal-pjanta f'solvent) (bħall-etanol jew bħall-ilma), biex jinħallu l-komponenti u jiffurmaw estratt likwidu.
English: What is horsetail herb?
Maltese: X'inhu denb iż-żiemel?
English: The HMPC conclusions only cover horsetail herb preparations which are obtained by drying and comminuting (reducing into tiny pieces) the aerial parts of the plant, by expressing the juice of the fresh aerial parts and as dry or liquid extracts from the dried aerial parts.
Maltese: Il-konklużjonijiet tal-HMPC ikopru biss preparazzjonijiet ta' denb iż-żiemel li huma miksuba billi jintaħnu (f'biċċiet iżgħar) l-partijiet ta' fuq tal-pjanta, billi jingħasar il-meraq tal-partijiet friski ta' fuq u bħala estratti niexfin jew likwidi mill-partijiet niexfin ta' fuq.
English: The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing horsetail herb.
Maltese: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: 2.1 Critical Evaluation
Maltese: 2.1 Evalwazzjoni kritika
English: Septicaemia
Maltese: Septikamija
English: • Female genital infections.
Maltese: • Infezzjonijiet fil-ġenitali femminili.
English: • Acute otitis media
Maltese: • Otitis media akuta
English: Intra-abdominal sepsis
Maltese: Sepsis intra-addominali
English: “Symptoms and signs of overdose
Maltese: “Sintomi u sinjali ta' doża eċċessiva
English: • Pelvic cavity
Maltese: • Il-kavità pelvika
English: History of jaundice/hepatic impairment due to amoxicillin/clavulanic acid (see section 4.8).”
Maltese: Passat ta' suffejra/indeboliment tal-fwied minħabba amoxicillin/clavulanic acid (ara sezzjoni 4.8).”
English: Amoxicillin/clavulanic acid is not recommended for intra-abdominal sepsis.
Maltese: Amoxicillin/clavulanic acid mhuwiex irrakkomandat għal sepsis intra-addominali.
English: Tonsilitis
Maltese: Tonsillite
English: Proposals were made for each sub-section (“Mode of Action” and “Mechanisms of resistance”, “PK/PD relationship” and “Breakpoints”).
Maltese: Saru proposti għal kull sub-sezzjoni (“Mod ta' Azzjoni” u “Mekkaniżmi ta' reżistenza”, “Relazzjoni PK/PD” u “Breakpoints”).
English: THERAPEUTIC INDICATIONS COMMON TO AUGMENTIN 2:1, 4:1, 7:1 AND 8:1 RATIO (ORAL)
Maltese: INDIKAZZJONIJIET TERAPEWTIĊI KOMUNI GĦAL PROPORZJON TA' AUGMENTIN 2:1, 4:1, 7:1 U 8:1 RATIO (ORALI)
English: The tablet has one immediate-release amoxicillin trihydrate (562.5mg) and clavulanic acid (62.5mg) layer, and one sustained-release sodium amoxicillin (437.5mg) layer.
Maltese: Il-pillola għandha saff ta' rilaxx immedjat ta' amoxicillin trihydrate (562.5mg) u clavulanic acid (62.5mg), u saff ta' rilaxx fit-tul ta' sodium amoxicillin (437.5mg).
English: The data forms the basis of the corresponding sections in the proposed harmonised SPCs.
Maltese: Id-dejta tifforma l-bażi tas-sezzjonijiet korrispondenti fl-SPCs armonizzati proposti.
English: • Biliary tract surgery.
Maltese: • Il-kirurġija tal-apparat biljari.
English: However, for 1.1 g amoxicillin/clavulanic acid given intravenously three times daily, T>MIC was present for 40% of the dosing interval for pathogens with an MIC of up to 4 μg/mL.
Maltese: Madankollu, għal 1.1 g amoxicillin/clavulanic acid mogħti minn ġol-vina tliet darbiet kuljum, T>MIC kien preżenti għal 40% tal-intervall ta' dożar għal patoġeni b'MIC sa 4 μg/mL.
English: Augmentin ES suspension is recommended for dosing at 90/6.4 mg/kg/day in two divided doses at 12-hourly intervals for 10 days.
Maltese: Is-suspensjoni Augmentin ES hija rrakkomandata għal dożar ta' 90/6.4 mg/kg/kuljum f'żewġ dożi separati f'intervalli ta' 12-il siegħa għal 10 t'ijiem.
English: The MAH listed the currently approved indications and discussed respiratory tract infections (RTIs), AOM, community acquired pneumonia (CAP), tonsillo-pharyngitis and sinusitis, skin and soft tissue infections (SSTI) and urinary tract infections (UTI).
Maltese: Il-MAH elenka l-indikazzjonijiet approvati attwalment u ddiskuta l-infezzjonijiet tal-apparat respiratorju (RTIs), AOM, pnewmonja li tittieħed mill-komunità (CAP), tonsillo-farinġite u sinużite, infezzjonijiet tal-ġilda u tat-tessut artab (SSTI) u infezzjonijiet tal-apparat urinarju (UTI).
English: For infections other than acute media otitis, initial antibiotic therapy is not usually recommended.
Maltese: Għall-infezzjonijiet li mhumiex media otitis akuta, normalment, it-terapija antibiotika tal-bidu mhijiex irrakkomandata.
English: Statements regarding the treatment of elderly patients (>60 years), the possible effect of amoxicillin on glucose tests, Glucose-Galactose Malapsorption and false-positive test results with the Platelia Aspergillus antigen test during treatment were discussed.
Maltese: Ġew diskussi d-dikjarazzjonijiet li jirrigwardaw il-kura ta' pazjenti anzjani (>60 sena), l-effett possibbli ta' amoxicillin fuq testijiet tal-glucose, Glucose-Galactose Malapsorption u testijiet pożittivi foloz bit-test antiġen ta' Platelia Aspergillus waqt il-kura.
English: “Augmentin is indicated for the treatment of the following infections in children aged at least 3 months and less than 40 kg body weight, caused or thought likely to be caused by penicillin-resistant Streptococcus pneumoniae (see sections 4.2, 4.4 and 5.1):
Maltese: “Augmentin huwa indikat għat-trattament tal-infezzjonijiet li ġejjin fit-tfal ta' età minima ta' 3 xhur u b'piż tal-ġisem ta' inqas minn 40 kg, ikkawżati jew probabbilment ikkawżati minn Streptococcus pneumoniae li huma reżistenti għall-peniċillina (ara s-sezzjonijiet 4.2, 4.4 u 5.1):
English: Gastrointestinal symptoms and disturbance of the fluid and electrolyte balances may be evident.
Maltese: Sintomi gastrointestinali u disturb tal-bilanċ tal-fluwidu u tal-elettroliti jistgħu jkunu evidenti.
English: Similarly, Sections 6.1, 6.2, 6.3, 6.4 and 6.5 will also be completed nationally.
Maltese: Bl-istess mod, is-Sezzjonijiet 6.1, 6.2, 6.3, 6.4 u 6.5 ukoll għandhom jimtlew min-naħa nazzjonali.
English: A regular check of patency should be maintained (see section 4.4).
Maltese: Għandu jsir kontroll regolari tal-patenza (ara sezzjoni 4.4).
English: The CHMP adopted the indications “Cystitis” and “Pyelopnephritis”.
Maltese: Il-CHMP adotta l-indikazzjonijiet “Ċistite” u “Pjelonefrite”.
English: Thus, the maximum daily dose of amoxicillin delivered with the 2:1 ratio is 750 mg.
Maltese: Għaldaqstant, id-doża massima ta' kuljum ta' amoxicillin li tingħata bil-proporzjon 2:1 hija ta' 750 mg.
English: The MAH listed the currently approved indications and discussed data from clinical trials in paediatric patients and adults in the treatment of otitis media and UTIs, demonstrating the bioequivalence of the 8:1 adult regimen to the 8:1 paediatric regimen and the efficacy of the 8:1 ratio BID in adults; consequently this regimen has now become well established in France for the treatment of respiratory tract infections in adults, including CAP, AECB, acute bronchitis, AOM and sinusitis.
Maltese: Il-MAH elenka l-indikazzjonijiet approvati attwalment u ddiskuta dejta minn provi kliniċi f'pazjenti pedjatriċi u f'adulti fit-trattament ta' otitis media u UTIs, u b'hekk wera l-bijoekwivalenza tar-reġim tal-adulti 8:1 mar-reġim pedjatriku 8:1 u l-effikaċja tal-proporzjon 8:1 BID fl-adulti; għalhekk dan ir-reġim issa sar stabbilit sew fi Franza għat-trattament ta' infezzjonijiet tal-apparat respiratorju fl-adulti, inklużi CAP, AECB, bronkite akuta, AOM u sinużite.
English: Two intravenous ratios have been developed: a 5:1 and a 10:1 formulation.
Maltese: Ġew żviluppati żewġ proporzjonijiet minn ġol-vina: formulazzjoni ta' 5:1 u ta' 10:1.
English: Augmentin ES (extra strength), paediatric suspension, was developed using clinical studies in AOM (Acute Otitis Media) and PK/PD data from animal models, to provide improved eradication of Penicillin resistant S. pneumoniae (PRSPs) with penicillin MICs up to and including 4g/mL.
Maltese: Augmentin ES (qawwa miżjuda), suspensjoni pedjatrika, ġie żviluppat bl-użu ta' studji kliniċi f'AOM (Otitis Media Akuta) u dejta tal-PK/PD minn mudelli tal-annimali, sabiex jipprovdi qerda mtejba ta' S. pneumoniae li huma reżistenti għall-Peniċillina (PRSPs) b'MICs tal-peniċillina sa u li jinkludu 4g/mL.
English: The MAH discussed and assessed a number of indications in light of the MAH Global Data Sheets (GDS), published data, literature, relevant studies and current clinical practice.
Maltese: Il-MAH iddiskuta u vvaluta għadd ta' indikazzjonijiet fiddawl tal-Folji ta' Dejta Globali tal-MAH (Global Data Sheets - GDS), dejta ppubblikata, litteratura, studji rilevanti u prattika klinika attwali.
English: Augmentin is a well-established and widely-used antibacterial combination product consisting of the semi-synthetic antibiotic amoxicillin (as amoxicillin trihydrate) and the -lactamase inhibitor clavulanic acid (as the potassium salt).
Maltese: Augmentin huwa prodott ta' kombinazzjoni antibatterjali li huwa stabbilit sewwa u użat ħafna u huwa magħmul mill-antibijotiku semi-sintetiku amoxicillin (bħala amoxicillin trihydrate) u mill-inibitur lactamase clavulanic acid (bħala l-melħ tal-potassju).
English: The published amoxicillin PK/PD data therefore support the continuing effectiveness against many pathogens of the 250/125mg (2:1) TID and 500/125mg (4:1) TID Augmentin oral formulations.
Maltese: Id-dejta PK/PD ta' amoxicillin ippubblikata għalhekk tappoġġa t-tkomplija tal-effikaċja kontra bosta patoġeni talformulazzjonijiet orali ta' Augmentin ta' 250/125mg (2:1) TID u 500/125mg (4
English: Genito-Urinary tract infections
Maltese: Infezzjoniiet fl-apparat Ġenito-Urinarju
English: The CHMP concluded that the 8:1 ratio is comparable to the 7:1 ratio in terms of efficacy and safety data.
Maltese: Il-CHMP ikkonkluda li l-proporzjon 8:1 huwa komparabbli mal-proporzjon 7:1 f'termini ta' effikaċja u dejta ta' sigurtà.
English: A recommended therapy is amoxicillin/clavulanic acid, especially if no bacteriological markers are available.
Maltese: Terapija rakkomandata hija amoxicillin/clavulanic acid, b'mod speċjali jekk ma jkun hemm ebda markatur batterjoloġiku disponibbli.
English: Some infections (e.g. osteomyelitis) require longer periods of treatment.
Maltese: Xi infezzjonijiet (pereżempju osteomjelite) jeħtieġu perijodi itwal ta' trattament.